Rigshospitalet-Copenhagen University Hospital

Copenhagen DK-2100

3 studies enrolling now · 20 studies all time

What they study most

Acute Coronary Syndrome, Acute Myeloid Leukemia, Acute Myocardial Infarction, Bladder Cancer, Breast Cancer, Breast Neoplasms, COVID-19 Pneumonia, Cancer of the Prostate, Cardiovascular Diseases, Cervical Cancer, Cervix Cancer, Colorectal Cancer (CRC), Coronary Artery Disease

Studies at this site

• Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment — Recruiting now
• Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease — Recruiting now
• Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF" — Recruiting now
• GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors — Running, not enrolling
• GEN1047 for Solid Tumors - First in Human (FIH) Trial — Stopped early
• Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) — Running, not enrolling
• A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination — Paused
• A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON) — Running, not enrolling
• Guadecitabine Extension Study — Stopped early
• SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction — Completed
• Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors — Completed
• A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors — Stopped early
• An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension — Completed
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors — Completed
• A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia — Completed
• Treatment for Endogenous Cushing's Syndrome — Completed
• Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors — Completed
• LEADERS FREE II: BioFreedom™ Pivotal Study — Running, not enrolling
• Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy — Completed
• Transfusion Requirements in Cardiac Surgery III — Completed